Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 752

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 752
---
vements to Income Tax Disclosures , or ASU 2023-09, which applies to all entities subject to income taxes. ASU 2023-09 requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. ASU 2023-09 is intended to provide more detailed income tax disclosures. For public business entities (PBEs), the new requirements will be effective for annual periods beginning after December 15, 2024. ASU 2023-09 will be applied on a prospective basis with the option to apply the standard retrospectively. The Company expects to adopt ASU 2023-09 on January 1, 2025, and it does not expect the adoption to have a material effect on its results of operations, financial position, and cash flows.

<div align='center'>F-11</div>

TABLE OF CONTENTS

CARA THERAPEUTICS, INC. NOTES TO CONDENSED FINANCIAL STATEMENTS
(amounts in thousands, except share and per share data)
(unaudited) 3. Available-for-Sale Marketable Securities As of September 30, 2024, the Company’s available-for-sale marketable securities consisted of debt securities issued by U.S. government-sponsored entities. As of December 31, 2023, the Company’s available-for-sale marketable securities consisted of debt securities issued by the U.S. Treasury, U.S. government-sponsored entities and investment grade institutions (corporate bonds). The following tables summarize the Company’s available-for-sale marketable securities by major type of security as of September 30, 2024 and December 31, 2023: As of September 30, 2024

| Type of Security                               
 ​                                              | ​     
 Gains | ​ | AmortizedCost |   |     ​ | ​ | ​      
 Losses | ​ | Gross Unrealized |   | ​ |   |   |   |   |   |     |   | ​ | ​ | EstimatedFair Value |   |       |   | ​ |
|:-----------------------------------------------|:------|:--|:--------------|:--|------:|:--|:-------|:--|:-----------------|:--|:--|:--|:--|:--|:--|:--|----:|:--|:--|:--|:--------------------|:--|------:|:--|:--|
| U